why should you rotate injection sites for semaglutide Sites: Clinical Guide & Best Prac... – PlexusDx Rotation of Injection Sites for

Side effect documentation with severity ratings and duration

Orforglipron is projected to generate about $1.6 billion in revenue in 2026, compared with $11.4 billion for Wegovy, which itself is seen easing from roughly $12.4 billion in 2025 as competition intensifies

Proper labeling prevents accidental mix-ups between different concentration vials

People move from Mounjaro (tirzepatide) to Wegovy (semaglutide) for many reasons such as better sideeffect profile, personal preference, supply, or cost (recent UK price changes have prompted many to consider alternatives)

Here is how the evidence splits

When I got there, the question was what was I going to do, what was my project going to be? Raufman recalls